fenbufen structure
|
Common Name | fenbufen | ||
|---|---|---|---|---|
| CAS Number | 36330-85-5 | Molecular Weight | 254.281 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 470.2±28.0 °C at 760 mmHg | |
| Molecular Formula | C16H14O3 | Melting Point | 184-187ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | 252.3±20.5 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of fenbufenFenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class. |
| Name | fenbufen |
|---|---|
| Synonym | More Synonyms |
| Description | Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 470.2±28.0 °C at 760 mmHg |
| Melting Point | 184-187ºC(lit.) |
| Molecular Formula | C16H14O3 |
| Molecular Weight | 254.281 |
| Flash Point | 252.3±20.5 °C |
| Exact Mass | 254.094299 |
| PSA | 54.37000 |
| LogP | 3.13 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.585 |
| InChIKey | ZPAKPRAICRBAOD-UHFFFAOYSA-N |
| SMILES | O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1 |
| Water Solubility | Very slightly soluble in water, slightly soluble in acetone, in ethanol (96 per cent) and in methylene chloride. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T: Toxic; |
| Risk Phrases | R25 |
| Safety Phrases | 28-45 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | DV1761000 |
| Packaging Group | III |
| Hazard Class | 6.1 |
| HS Code | 2921440000 |
| Precursor 10 | |
|---|---|
| DownStream 9 | |
| HS Code | 2918300090 |
|---|---|
| Summary | 2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorg. Med. Chem. 17 , 896-904, (2009) This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret... |
|
|
Thermodynamic studies of Fenbufen, Diflunisal, and Flurbiprofen: sublimation, solution and solvation of biphenyl substituted drugs.
Int. J. Pharm. 357(1-2) , 100-7, (2008) Temperature dependency of saturated vapour pressure for Fenbufen (FBF) was obtained. Heat capacities for Fenbufen, Diflunisal (DIF), and Flurbiprofen (FBP) were measured, and standard thermodynamic fu... |
|
|
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Bioorg. Med. Chem. 18 , 7486-96, (2010) The displacement of probes that bind selectively to subdomains IIA or IIIA on human serum albumin (HSA) by competing compounds has been followed using fluorescence spectroscopy, and has therefore been... |
|
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
Source: 824
External Id: CYP273
|
|
Name: Increase the activity of the Burkholderia fixLJ 2-component system
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Burkholderia multivorans
External Id: HMS1625
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: Inhibition of human DHFR in presence of DHF and NADPH by UV-vis spectrometry by Linew...
Source: ChEMBL
Target: Dihydrofolate reductase
External Id: CHEMBL4621660
|
|
Name: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
Source: NCGC
External Id: HERG01
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Pla...
Source: Broad Institute
Target: CAAX prenyl protease 2 [Homo sapiens]
External Id: 2034-04_Inhibitor_Dose_CherryPick_Activity
|
|
Name: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
Source: Burnham Center for Chemical Genomics
Target: cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id: SBCCG-A764-CF-PAF-Primary-Assay
|
| Lederfen |
| Napanol |
| 4-oxo-4-(4-phenylphenyl)butanoic acid |
| Cinopal |
| 4-(Biphenyl-4-yl)-4-oxobutanoicAcid |
| 4-(4-Biphenylyl)-4-oxobutanoic acid |
| MFCD00056701 |
| fenbufen |
| 4-(Biphenyl-4-yl)-4-oxobutanoic Acid |
| EINECS 252-979-0 |
| Bufemid |
| 4-(4-Biphenylyl)-4-oxobutyric acid |